These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6633824)

  • 21. Proceedings: Anticonvulsant properties of a series of new 2, 5-pyrrolidone derivatives.
    Rump S
    Act Nerv Super (Praha); 1975; 17(4):244-5. PubMed ID: 1221779
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticonvulsant activity of some 4-aminophenylacetamides.
    Clark CR; Davenport TW
    J Pharm Sci; 1987 Jan; 76(1):18-20. PubMed ID: 3585717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of opioid antagonists on anticonvulsant and hypnotic activity of benzodiazepines.
    Fidecka S; Langwiński R
    Pol J Pharmacol; 1996; 48(4):409-14. PubMed ID: 9112681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A spirohydantoin derivative of oxymorphone: an agonist with delayed antagonist activity.
    Alexander GJ; Chatterjie N; Wisniewski HM
    Pharmacol Biochem Behav; 1989 Apr; 32(4):939-43. PubMed ID: 2477864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anticonvulsant evaluation of 1,2-diphenylethane derivatives, potential metabolites of denzimol.
    Catto A; Rossi A; Leonardi A; Testa R; Nardi D
    Farmaco; 1989 Jun; 44(6):595-607. PubMed ID: 2803448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An experimental evaluation of the anticonvulsant activity of some antihistaminic drugs.
    Saxena VC; Bapat SK; Dhawan BN
    Jpn J Pharmacol; 1969 Dec; 19(4):477-84. PubMed ID: 4391520
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 3-aryl-2-thiohydantoin- and 3-arylhydantoin-5-acetic acids and screening of some of their pharmacological properties.
    Korohoda MJ; Bojarska AB; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(5):423-7. PubMed ID: 827740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of p-nitrophenyl substituted semicarbazones for anticonvulsant properties.
    Pandeya SN; Ponnilavarasan I; Pandey A; Lakhan R; Stables JP
    Pharmazie; 1999 Dec; 54(12):923-5. PubMed ID: 10631757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticonvulsants. 3. Phenobarbital and mephobarbital derivatives.
    Vida JA; Hooker ML
    J Med Chem; 1973 Jun; 16(6):602-5. PubMed ID: 4714988
    [No Abstract]   [Full Text] [Related]  

  • 32. Search for new anticonvulsant compounds. Part 1: Synthesis, physicochemical and anticonvulsant properties of new derivatives of alpha-amino-gamma-phthalimidobutyric acid.
    Malawska B; Zejc A
    Pharmazie; 1995 Nov; 50(11):722-5. PubMed ID: 8570669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant activity of Schiff bases of isatin derivatives.
    Verma M; Pandeya SN; Singh KN; Stables JP
    Acta Pharm; 2004 Mar; 54(1):49-56. PubMed ID: 15050044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity correlations for anticonvulsant drugs.
    Lien EJ
    J Med Chem; 1970 Nov; 13(6):1189-91. PubMed ID: 5479864
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the effect of anticonvulsants on the electroshock seizure induced through condenser discharge method.
    YOSHII N; HORIGUCHI T; HASHINO S; KOYASU Y
    Folia Psychiatr Neurol Jpn; 1953 Mar; 6(4):285-9. PubMed ID: 13095547
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and Anticonvulsant Activity of Substituted-1,3-diazaspiro[4.5]decan-4-ones.
    Aboul-Enein MN; El-Azzouny AA; Saleh OA; Amin KM; Maklad YA; Hassan RM
    Arch Pharm (Weinheim); 2015 Aug; 348(8):575-88. PubMed ID: 26032619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test.
    BROWN WC; SCHIFFMAN DO; SWINYARD EA; GOODMAN LS
    J Pharmacol Exp Ther; 1953 Mar; 107(3):273-83. PubMed ID: 13035666
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of calcium channel blockers on pentylenetetrazol and electroshock-induced convulsions in mice.
    Jagiełło-Wójtowicz E; Czuczwar SJ; Chodkowska A; Szponar J; Kleinrok Z
    Pol J Pharmacol Pharm; 1991; 43(2):95-101. PubMed ID: 1946038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cold-restraint and swim stress on convulsions induced by pentylenetetrazol and electroshock: influence of naloxone pretreatment.
    De Lima TC; Rae GA
    Pharmacol Biochem Behav; 1991 Oct; 40(2):297-300. PubMed ID: 1805234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.